Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab
Identificadores
Identificadores
Data de publicación
2013Título da revista
Clinical Colorectal Cancer
Tipo de contido
Artigo